Frances K Heller - Net Worth and Insider Trading
Frances K Heller Net Worth
The estimated net worth of Frances K Heller is at least $39,252 dollars as of 2024-04-25. Frances K Heller is the EVP, Business Development of Exelixis Inc and owns about 1,500 shares of Exelixis Inc (EXEL) stock worth over $35,295. Frances K Heller is also the Director of Zafgen Inc and owns about 3,997 shares of Zafgen Inc (ZFGN) stock worth over $3,957. Details can be seen in Frances K Heller's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Frances K Heller has not made any transactions after 2017-10-13 and currently still holds the listed stock(s).
Transaction Summary of Frances K Heller
Frances K Heller Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Frances K Heller owns 4 companies in total, including Larimar Therapeutics Inc (LRMR) , Bristol-Myers Squibb Co (BMY) , and Exelixis Inc (EXEL) among others .
Click here to see the complete history of Frances K Heller’s form 4 insider trades.
Insider Ownership Summary of Frances K Heller
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
LRMR | Larimar Therapeutics Inc | 2015-07-13 | director |
BMY | Bristol-Myers Squibb Co | 2013-10-01 | SVP & Business Development |
EXEL | Exelixis Inc | 2009-11-02 | EVP & Business Development |
MTRY | Monterey Innovation Acquisition Corp | 2021-09-30 | director |
Frances K Heller Latest Holdings Summary
Frances K Heller currently owns a total of 2 stocks. Among these stocks, Frances K Heller owns 1,500 shares of Exelixis Inc (EXEL) as of November 2, 2009, with a value of $35,295 and a weighting of 89.92%. Frances K Heller also owns 3,997 shares of Zafgen Inc (ZFGN) as of October 13, 2017, with a value of $3,957 and a weighting of 10.08%.
Latest Holdings of Frances K Heller
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
EXEL | Exelixis Inc | 2009-11-02 | 1,500 | 23.53 | 35,295 |
ZFGN | Zafgen Inc | 2017-10-13 | 3,997 | 0.99 | 3,957 |
Holding Weightings of Frances K Heller
Frances K Heller Form 4 Trading Tracker
According to the SEC Form 4 filings, Frances K Heller has made a total of 0 transactions in Exelixis Inc (EXEL) over the past 5 years. The most-recent trade in Exelixis Inc is the sale of 2,529 shares on November 2, 2009, which brought Frances K Heller around $15,655.
According to the SEC Form 4 filings, Frances K Heller has made a total of 0 transactions in Zafgen Inc (ZFGN) over the past 5 years. The most-recent trade in Zafgen Inc is the acquisition of 833 shares on October 13, 2017, which cost Frances K Heller around $39,000.
Insider Trading History of Frances K Heller
- 1
Frances K Heller Trading Performance
GuruFocus tracks the stock performance after each of Frances K Heller's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frances K Heller is 26.88%. GuruFocus also compares Frances K Heller's trading performance to market benchmark return within the same time period. The performance of stocks bought by Frances K Heller within 3 months outperforms 4 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Frances K Heller's insider trading performs compared to the benchmark.
Performance of Frances K Heller
Average Return
46.21%
Outperforming Transactions
100%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 2.13 | 26.88 | 37.85 | 46.21 | 31.11 | -36.25 |
Relative Return to S&P 500(%) | 0.78 | 21.78 | 31.08 | 31.66 | 21.46 | -48.3 |
Frances K Heller Ownership Network
Ownership Network List of Frances K Heller
Ownership Network Relation of Frances K Heller
Frances K Heller Owned Company Details
What does Larimar Therapeutics Inc do?
Who are the key executives at Larimar Therapeutics Inc?
Frances K Heller is the director of Larimar Therapeutics Inc. Other key executives at Larimar Therapeutics Inc include 10 percent owner & other: Possible Member of 10% Group James E Flynn , Chief Development Officer Gopi Shankar , and Chief Medical Officer Russell Clayton .
Larimar Therapeutics Inc (LRMR) Insider Trades Summary
Over the past 18 months, Frances K Heller made no insider transaction in Larimar Therapeutics Inc (LRMR). Other recent insider transactions involving Larimar Therapeutics Inc (LRMR) include a net purchase of 4,290,617 shares made by James E Flynn , a net purchase of 5,000 shares made by Carole Ben-maimon , and a net purchase of 5,000 shares made by Gopi Shankar .
In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc (LRMR) in total and bought 4,292,617 shares, with a net purchase of 4,292,617 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc (LRMR) were sold and 4,310,367 shares were bought by its insiders, resulting in a net purchase of 4,310,367 shares.
Larimar Therapeutics Inc (LRMR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Larimar Therapeutics Inc Insider Transactions
Frances K Heller Mailing Address
Above is the net worth, insider trading, and ownership report for Frances K Heller. You might contact Frances K Heller via mailing address: 249 E. Grand Avenue, S. San Francisco Ca 94083.